NT PHARMA (01011) will be suspended from trading starting February 10, awaiting the publication of supplementary information related to the issuance of convertible bonds.

date
12:28 10/02/2026
avatar
GMT Eight
Tailin Pharmaceuticals (01011) announced that trading of the company's shares will be suspended on the Hong Kong Stock Exchange from 9:03 a.m. on February 10, 2026, pending the publication of supplementary information related to the announcement on February 9, 2026 regarding the issuance of convertible bonds under general authorization.
NT PHARMA (01011) announced that trading of the company's shares on the Stock Exchange of Hong Kong Limited will be suspended from 9:03 am on February 10, 2026, pending the publication of supplemental information regarding the announcement of the issuance of convertible bonds under the general authorization on February 9, 2026.